Search - tctmd.com

Displaying 81 - 100 of 297

Sort: Relevancy | Date

Presentation THT 2024

Transcatheter pulmonary artery banding [PAB] for HFrEF: Initial results of invasive exercise hemodynamics and updates from the ongoing First-in-Human trial.

Presenter: Sean P. Pinney

March 06, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT 2024

RECOVER-HF Pilot Study: Synchronized Diaphragmatic Stimulation for HFrEF Therapy

Presenter: Marat Fudim

March 05, 2024

Presentation THT 2024

Patient Identification and Post-implant Management within an Advanced Heart Failure Program

Presenter: Dmitry Yaranov

March 05, 2024

Presentation THT 2024

Beyond BeAT-HF: Real-world Experience with Barostim

Presenter: gurusher panjrath

March 05, 2024

Presentation THT 2024

Long-term Results of the BeAT-HF Clinical Study

Presenter: JoAnn Lindenfeld

March 05, 2024

Presentation THT 2024

Challenges and Opportunities with Contemporary GDMT

Presenter: James Thomas Heywood

March 05, 2024

Presentation THT 2024

RESTORE Medical: Transcatheter Pulmonary Artery Banding for Patients With HFrEF

Presenter: Gilad Marom

March 05, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

Vsling- Ventricular repair device for HFrEF patients

Presenter: Boaz Manash

March 04, 2024

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Presentation THT Abstracts 2024

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

Presenter: Marvin Konstam

March 04, 2024

Presentation THT 2024

When to consider AccuCinch

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

Transcatether Left Ventricular Restoration (TLVR): The AccuCinch Approach

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Why Treat The Dilated Left Ventricle

Presenter: Daniel Burkhoff

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

Advertisement

Transcatheter pulmonary artery banding [PAB] for HFrEF: Initial results of invasive exercise hemodynamics and updates from the ongoing First-in-Human trial.

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

RECOVER-HF Pilot Study: Synchronized Diaphragmatic Stimulation for HFrEF Therapy

Patient Identification and Post-implant Management within an Advanced Heart Failure Program

Beyond BeAT-HF: Real-world Experience with Barostim

Long-term Results of the BeAT-HF Clinical Study

Challenges and Opportunities with Contemporary GDMT

RESTORE Medical: Transcatheter Pulmonary Artery Banding for Patients With HFrEF

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Vsling- Ventricular repair device for HFrEF patients

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

When to consider AccuCinch

Transcatether Left Ventricular Restoration (TLVR): The AccuCinch Approach

Why Treat The Dilated Left Ventricle

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

March 2024 Dispatch for the CV Team

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

GDMT Rates Low in HFrEF, Particularly in Women

January 2024 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content